HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hiroshi Hara Selected Research

difructose anhydride III (DFA III)

11/2017Impact of difructose anhydride III, raffinose, and fructooligosaccharides on energy intake, gut hormones, and cecal fermentation in rats fed a high-fat and high-sucrose diet.
10/2006Ingestion of difructose anhydride III, a non-digestible disaccharide, improves postgastrectomy osteopenia in rats.
7/2006Ingestion of difructose anhydride III, a non-digestible disaccharide, prevents gastrectomy-induced iron malabsorption and anemia in rats.
6/2005Effects of difructose anhydride III (DFA III) administration on bile acids and growth of DFA III-assimilating bacterium Ruminococcus productus on rat intestine.
11/2003Ingestion of an indigestible saccharide, difructose anhydride III, partially prevents the tannic acid-induced suppression of iron absorption in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hiroshi Hara Research Topics

Disease

12Obesity
06/2021 - 03/2010
10Glucose Intolerance
06/2021 - 08/2004
10Graft vs Host Disease (Graft-Versus-Host Disease)
08/2008 - 07/2002
6Body Weight (Weight, Body)
01/2019 - 04/2004
6Anemia
12/2018 - 04/2003
5Inflammation (Inflammations)
08/2015 - 06/2011
5Insulin Resistance
01/2014 - 08/2004
5Colitis
01/2013 - 06/2011
5Metabolic Bone Diseases (Osteopenia)
10/2010 - 07/2002
4Metabolic Syndrome (Dysmetabolic Syndrome X)
11/2014 - 06/2008
4Neoplasm Metastasis (Metastasis)
01/2011 - 01/2003
4Thrombotic Microangiopathies
09/2006 - 10/2004
4Thrombotic Thrombocytopenic Purpura
04/2006 - 10/2004
3Hyperglycemia
01/2018 - 07/2010
3Carcinogenesis
06/2012 - 09/2010
3Colorectal Neoplasms (Colorectal Cancer)
12/2010 - 06/2005
3Leukemia
08/2008 - 02/2004
3Hematologic Neoplasms (Hematological Malignancy)
08/2008 - 01/2005
2Delirium
01/2021 - 01/2020
2Cognitive Dysfunction
01/2016 - 01/2015
2Coronary Artery Disease (Coronary Atherosclerosis)
01/2015 - 11/2014
2Atherosclerosis
11/2014 - 01/2014
2Rheumatoid Arthritis
08/2014 - 10/2012
2Carcinoma (Carcinomatosis)
01/2011 - 05/2007
2Urolithiasis
05/2009 - 09/2007
2Neoplasms (Cancer)
05/2007 - 01/2003
2Adenocarcinoma
05/2007 - 01/2003
2Hemolytic-Uremic Syndrome
01/2005 - 10/2004
2Infections
08/2003 - 10/2002
2Colonic Neoplasms (Colon Cancer)
01/2003 - 01/2002
1Stroke (Strokes)
01/2021
1Alcoholic Fatty Liver
06/2019
1Non-alcoholic Fatty Liver Disease
12/2018
1Iron Deficiencies
12/2018
1Hyperphagia (Overeating)
01/2018

Drug/Important Bio-Agent (IBA)

15Glucagon-Like Peptide 1 (GLP 1)IBA
06/2021 - 07/2010
7Glucose (Dextrose)FDA LinkGeneric
06/2021 - 08/2004
6IronIBA
12/2018 - 04/2003
6CytokinesIBA
08/2015 - 10/2002
5PlasmalogensIBA
06/2019 - 06/2008
5Sucrose (Saccharose)IBA
01/2019 - 11/2009
5difructose anhydride III (DFA III)IBA
11/2017 - 11/2003
5Dextran SulfateIBA
01/2013 - 06/2011
5CalciumIBA
10/2010 - 07/2002
4QuercetinIBA
06/2021 - 01/2002
4thiamine triphosphorate (TTP)IBA
04/2006 - 10/2004
3Insulin (Novolin)FDA Link
01/2019 - 11/2009
3LipidsIBA
12/2018 - 01/2013
3Inositol (Myoinositol)IBA
01/2016 - 06/2008
3HydrogenIBA
08/2015 - 10/2012
3Biomarkers (Surrogate Marker)IBA
01/2015 - 08/2014
3Bile Acids and Salts (Bile Acids)IBA
01/2014 - 09/2010
3EnzymesIBA
01/2013 - 09/2004
3ZincIBA
12/2012 - 02/2007
3Phytic Acid (Inositol Hexaphosphate)IBA
12/2010 - 02/2007
3DisaccharidesIBA
10/2010 - 07/2006
3Proteins (Proteins, Gene)FDA Link
07/2010 - 03/2010
2Fatty Acids (Saturated Fatty Acids)IBA
06/2021 - 07/2010
2Lipoproteins (Lipoprotein)IBA
06/2019 - 11/2014
2psicose (D-psicose)IBA
02/2018 - 01/2018
2Hemoglobins (Hemoglobin)IBA
01/2016 - 07/2005
2Biological ProductsIBA
08/2015 - 07/2010
2Therapeutic UsesIBA
08/2015 - 08/2014
2Interleukin-6 (Interleukin 6)IBA
08/2015 - 08/2014
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2015 - 08/2014
2Phenobarbital (Luminal)FDA Link
05/2015 - 03/2010
2fructooligosaccharideIBA
01/2014 - 11/2008
2ZeinIBA
09/2013 - 07/2010
2Hormones (Hormone)IBA
01/2013 - 09/2002
2Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA
01/2013 - 07/2010
2AdipokinesIBA
10/2011 - 07/2010
2OligosaccharidesIBA
10/2011 - 07/2006
2epilactoseIBA
10/2010 - 11/2008
2Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA
07/2010 - 03/2007
2Peptides (Polypeptides)IBA
07/2010 - 10/2006
2AcidsIBA
11/2008 - 02/2006
2fludarabineIBA
08/2008 - 01/2006
2Tacrolimus (Prograf)FDA LinkGeneric
08/2008 - 02/2004
2Cyclosporine (Ciclosporin)FDA LinkGeneric
08/2008 - 01/2006
2Methotrexate (Mexate)FDA LinkGeneric
08/2008 - 01/2006
2Prostate-Specific Antigen (Semenogelase)IBA
05/2007 - 11/2004
2Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
09/2006 - 09/2004
2Interleukin-18 (Interleukin 18)IBA
11/2004 - 05/2004
2AntigensIBA
09/2004 - 08/2003
1SugarsIBA
06/2021
1Histamine H2 AntagonistsIBA
01/2021
1Histamine (Histamine Dihydrochloride)FDA Link
01/2021
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
12/2018
1Alanine Transaminase (SGPT)IBA
12/2018
1Triglycerides (Triacylglycerol)IBA
12/2018

Therapy/Procedure

9Bone Marrow Transplantation (Transplantation, Bone Marrow)
02/2007 - 07/2002
7Transplantation
08/2008 - 08/2003
5Gastrectomy
10/2010 - 07/2002
4Therapeutics
08/2008 - 06/2005
4Stem Cell Transplantation
06/2005 - 08/2003
2Critical Care (Surgical Intensive Care)
01/2021 - 01/2020
2Drug Therapy (Chemotherapy)
08/2008 - 10/2005
2Ovariectomy (Oophorectomy)
08/2005 - 02/2003
2Hematopoietic Stem Cell Transplantation
08/2005 - 01/2005
2Aftercare (After-Treatment)
01/2003 - 01/2002